Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Gains from Investment Securities (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Gains from Investment Securities for 2 consecutive years, with $230000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $230000.0 in Q1 2025 year-over-year; TTM through Dec 2025 was $230000.0, a 90.99% decrease, with the full-year FY2025 number at $230000.0, down 90.99% from a year prior.
  • Gains from Investment Securities was $230000.0 for Q1 2025 at Day One Biopharmaceuticals, down from $2.6 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.6 million in Q3 2024 to a low of $230000.0 in Q1 2025.